Karen Walton-Bowen joined Clinical Research Associates (CRA) in 2014 to oversee clinical operations, biostatistical analysis and reporting, and the rbaclofen program.

Walton-Bowen is an expert in clinical development across multiple therapeutic areas within the pharmaceutical and biotechnology industry, including gastrointestinal, neuroscience, respiratory, cardiovascular, lysosomal storage disorders, inflammation and pain control. Previously, Walton-Bowen worked at Seaside Therapeutics, L.L.C. as senior director of biometrics. There, she was responsible for the data-analytic aspects of the arbaclofen programs, which aimed to treat autism and fragile X Syndrome.

Walton-Bowen holds a B.Sc. in mathematics and computing and an M.Sc. in medical statistics from the University of London in the U.K. She also holds Chartered Statistician and Chartered Scientist status through the Royal Statistical Society.